
Jeffrey I Silberzweig
Associate Program Director, Internal Medicine Residency · New York Presbyterian Hospital
Credentials: ·
History
Research
Incidence of nephrogenic systemic fibrosis at two large medical centers
Radiology · 2008 · 218 citations
Mitigating Risk of COVID-19 in Dialysis Facilities
Clinical Journal of the American Society of Nephrology · 2020 · 124 citations
American Journal of Nephrology · 2003 · 82 citations

9 papers
- AK
5 papers

5 papers

5 papers

5 papers · 4 as a fellow
- DL
4 papers

4 papers

4 papers
Clinical trials
- 2018–2022
Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.
Principal investigator · Completed
The Rogosin Institute
- 2015–2029
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
Principal investigator · Suspended
Kaneka Medical America LLC
- 2015–2029
Principal investigator · Recruiting
Kaneka Medical America LLC



